Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02566174 · ClinicalTrials.gov registry record
Family Caregiving Role Adjustment and Dyadic Mutuality
A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 24
- Enrollment target
NCT02566174: Completed study, sponsored by National Institutes of Health Clinical Center (CC).
NCT02566174 is a clinical trial that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02566174 has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
Background: Cancer causes changes in the lives of patients and in the lives of their caregivers. Patients and caregivers feel stress and they affect each other as they deal with these changes. They each cope with cancer diagnosis and treatment on their own. They also cope together. Researchers want to explore this shared change of roles and responsibilities. They will do this by gaining insight into the social experience of cancer caregiving. They also want to better understand the ways caregiver/patient teams manage the cancer diagnosis and experience. This can help find new ways to support caregivers and their patients. Objective: To explore the shared change of roles and responsibilities of patients and caregivers by studying the social experience of cancer caregiving. Eligibility: English speakers ages 18 and older who are one of the following: A cancer patients at the NIH Clinical Center (CC) A caregiver of a CC cancer patient Design: Participants will have been screened by the CC. Patients and caregivers will be interviewed separately. This will last up to an hour and a half. Participants will complete online surveys. Participants may have a follow-up phone interview. This will last up to 15 minutes.
Primary Outcome
by gaining insights into the social experience of cancer family caregiving that will have application to practice and guide further study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2015-10-01 |
| Est. Completion | 2019-09-18 |
What the finished NCT02566174 record still lists
NCT02566174 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02566174 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02566174 about?
NCT02566174 is a clinical study titled "Family Caregiving Role Adjustment and Dyadic Mutuality". Background: Cancer causes changes in the lives of patients and in the lives of their caregivers. Patients and caregivers feel stress and they affect each other as they deal with these changes. They each cope with cancer diagnosis and treatment on their own. They also cope together. Researchers want...
What is the current status of trial NCT02566174?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2015-10-01. Estimated completion is 2019-09-18.
Who is sponsoring clinical trial NCT02566174?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI